NASDAQ:ELOX
Eloxx Pharmaceuticals Inc. Stock News
$0.85
-0.0100 (-1.16%)
At Close: May 08, 2024
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
08:48am, Tuesday, 05'th Dec 2023
While getting kicked off an exchange typically signals about the biggest warning sign you can possibly receive, a (somewhat) rational argument exists for delisted stocks to buy. Psychologically, compa
This Small Cap Stock Surged Over 100%
10:52am, Wednesday, 12'th Jul 2023
Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals NASDAQ: ELOX rocketed almost 100% yesterday after receiving an increased pric
Penny Stocks to Watch: Why Is ELOX Stock Skyrocketing?
03:06pm, Tuesday, 11'th Jul 2023
Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
08:49am, Tuesday, 16'th May 2023
Eloxx Pharmaceuticals (NASDAQ: ELOX ) stock is falling hard on Tuesday after the company provided a weak earnings report for Q1 2023. The bad news for ELOX stock starts with its losses per share of $2
Senesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
06:59pm, Monday, 15'th May 2023
Senesco Technologies Inc. (ELOX) came out with a quarterly loss of $2.88 per share versus the Zacks Consensus Estimate of a loss of $2.55. This compares to loss of $5.20 per share a year ago.
Eloxx Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
04:10pm, Monday, 06'th Mar 2023
WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that it will pr
5 Hot Penny Stocks Exploding After News This Week
09:39am, Thursday, 05'th Jan 2023
Hot penny stocks with news to watch this week. The post 5 Hot Penny Stocks Exploding After News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Eloxx (ELOX) Down After Cystic Fibrosis Study Fails to Meet Goal
12:48pm, Friday, 16'th Sep 2022
Eloxx Pharmaceuticals' (ELOX) phase II combination study evaluating pipeline candidate ELX-02 in cystic fibrosis fails to achieve statistical significance in efficacy endpoints.
Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome
08:15pm, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Strong rationale for development for Alport syndrome as ELOX-02 has demonstrated significant readthrough in COL4A5 nonsense mutations in preclinical studies and is preferentially transported to kidney
Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation
11:00am, Tuesday, 29'th Mar 2022 GlobeNewswire Inc.
Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program
Stock on fire: Evofem Biosciences, Inc. (NASDAQ:EVFM), Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX)
06:53am, Friday, 11'th Mar 2022 Stock Equity
Evofem Biosciences, Inc. (NASDAQ:EVFM) with the stream of -2.05% also noticed, India Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) encountered a rapid change of 12.90% in the last hour of Thursday’s trading session. … The post Stock on fire: Evofem Biosciences, Inc. (NASDAQ:EVFM), Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) appeared first on Stocks Equity .
Eloxx Pharmaceuticals Inc Shares Fall 5.6% Below Previous 52-Week Low - Market Mover
05:00am, Saturday, 15'th Jan 2022 Kwhen Finance
Eloxx Pharmaceuticals Inc (ELOX) shares closed 5.6% lower than its previous 52 week low, giving the company a market cap of $49M. The stock is currently down 19.4% year-to-date, down 85.9% over the past 12 months, and down 77.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 80.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 10.5% lower than its 5-day moving average, 20.9% lower than its 20-day moving average, and 53.9% lower than its 90-day moving average.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -691.8% The company's stock price performance over the past 12 months lags the peer average by 552.0%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Blustering Stock Grabbing Investors Attention: Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), Alibaba Group Holding Limited (NYSE:BABA)
12:07am, Monday, 20'th Dec 2021 Stock Equity
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) with the stream of 12.06% also noticed, India Alibaba Group Holding Limited (NYSE:BABA) encountered a rapid change of 1.54% in the last hour of Fridays trading The post Blustering Stock Grabbing Investors Attention: Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), Alibaba Group Holding Limited (NYSE:BABA) appeared first on Stocks Equity .
Eloxx Pharmaceuticals (NASDAQ:ELOX) Now Covered by Oppenheimer
06:56am, Saturday, 18'th Dec 2021 Transcript Daily
Investment analysts at Oppenheimer began coverage on shares of Eloxx Pharmaceuticals (NASDAQ:ELOX) in a note issued to investors on Thursday, Price Targets.com reports. The brokerage set an outperform rating and a $4.00 price target on the stock. Oppenheimers price target suggests a potential upside of 441.27% from the stocks previous close. ELOX has been the []
Popular Penny Stocks to Add to Your Watchlist Right Now
09:19pm, Friday, 17'th Dec 2021 PennyStocks
Check these three penny stocks out for your list right now
The post Popular Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt